Viewing Study NCT05681260

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-05-01 @ 5:07 PM
Study NCT ID: NCT05681260
Status: RECRUITING
Last Update Posted: 2025-02-13
First Post: 2022-12-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children with Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)
Sponsor: Children's Cancer Group, China
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None T-cell Lymphoblastic Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T-cell lymphoblastic lymphoma View
None Pediatric View
None Capizzi-style Methotrexate View
None High dose Methotrexate View
None bortezomib View
None treatment View
None survival View
None PET scan View